[1] |
Wang LF, Lin JY, Hsieh KH, et al. Epicutaneous exposure of protein antigen induces a predominant Th2⁃like response with high IgE production in mice[J]. J Immunol, 1996, 156(11): 4077⁃4082.
|
[2] |
Glenn GM, Rao M, Matyas GR, et al. Skin immunization made possible by cholera toxin[J]. Nature, 1998, 391(6670): 851.
|
[3] |
Tay SS, Roediger B, Tong PL, et al. The skin⁃resident immune network[J]. Curr Dermatol Rep, 2014, 3(1): 13⁃22.
|
[4] |
Jang S, Park JS, Won YH, et al. The of toll⁃like receptors (TLRs) in cultured human skin fibroblast is modulated by histamine[J]. Chonnam Med J, 2012, 48(1): 7⁃14. DOI: 10.4068/cmj.2012.48.1.7.
|
[5] |
Igyártó BZ, Haley K, Ortner D, et al. Skin⁃resident murine dendritic cell subsets promote distinct and opposing antigen⁃specific T helper cell responses[J]. Immunity, 2011, 35(2): 260⁃272. DOI: 10.1016/j.immuni.2011.06.005.
|
[6] |
Kumamoto Y, Linehan M, Weinstein JS, et al. CD301b+ dermal dendritic cells drive T helper 2 cell⁃mediated immunity[J]. Immunity, 2013, 39(4): 733⁃743. DOI: 10.1016/j.immuni.2013.08. 029.
|
[7] |
Nakajima S, Igyarto BZ, Honda T, et al. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling[J]. J Allergy Clin Immunol, 2012, 129(4): 1048⁃1055. DOI: 10.1016/j.jaci.2012.01.063.
|
[8] |
Strid J, Sobolev O, Zafirova B, et al. The intraepithelial T cell response to NKG2D⁃ligands links lymphoid stress surveillance to atopy[J]. Science, 2011, 334(6060): 1293⁃1297. DOI: 10.1126/science.1211250.
|
[9] |
Otsuka A, Kubo M, Honda T, et al. Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity[J]. PLoS One, 2011, 6(9): e25538. DOI: 10.1371/journal.pone.0025538.
|
[10] |
Novak N, Bieber T. 2. Dendritic cells as regulators of immunity and tolerance[J]. J Allergy Clin Immunol, 2008, 121(2 Suppl): S370⁃S374, S413. DOI: 10.1016/j.jaci.2007.06.001.
|
[11] |
Gomez De Agüero M, Vocanson M, Hacini⁃Rachinel F, et al. Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8+ T cells and activating Foxp3+ regulatory T cells[J]. J Clin Invest, 2012, 122(5): 1700⁃1711. DOI: 10.1172/JCI59725.
|
[12] |
Seneschal J, Clark RA, Gehad A, et al. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells[J]. Immunity, 2012, 36(5): 873⁃84. DOI: 10.1016/j.immuni.2012.03.018.
|
[13] |
Shklovskaya E, O′Sullivan BJ, Ng LG, et al. Langerhans cells are precommitted to immune tolerance induction[J]. Proc Natl Acad Sci U S A, 2011, 108(44): 18049⁃18054. DOI: 10.1073/pnas.1110076108.
|
[14] |
Rattanapak T, Birchall JC, Young K, et al. Dynamic visualization of dendritic cell⁃antigen interactions in the skin following transcutaneous immunization[J]. PLoS One, 2014, 9(2): e89503. DOI: 10.1371/journal.pone.0089503.
|
[15] |
Engelke L, Winter G, Hook S, et al. Recent insights into cutaneous immunization: How to vaccinate via the skin[J]. Vaccine, 2015, 33(37): 4663⁃74. DOI: 10.1016/j.vaccine.2015.05.012.
|
[16] |
Mittal A, Raber AS, Lehr CM, et al. Particle based vaccine formulations for transcutaneous immunization[J]. Hum Vaccin Immunother, 2013, 9(9): 1950⁃5. DOI: 10.4161/hv.25217.
|
[17] |
Matsuo K, Ishii Y, Quan YS, et al. Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat[J]. J Control Release, 2011, 149(1): 15⁃20. DOI: 10.1016/j.jconrel.2010.05.012.
|
[18] |
Mazzitelli S, Pagano C, Giusepponi D, et al. Hydrogel blends with adjustable properties as patches for transdermal delivery[J]. Int J Pharm, 2013, 454(1): 47⁃57. DOI: 10.1016/j.ijpharm.2013.06.081.
|
[19] |
Sloat BR, Kiguchi K, Xiao G, et al. Transcutaneous DNA immunization following waxing⁃based hair depilation[J]. J Control Release, 2012, 157(1): 94⁃102. DOI: 10.1016/j.jconrel.2011.08.038.
|
[20] |
Mittal A, Raber AS, Schaefer UF, et al. Non⁃invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization[J]. Vaccine, 2013, 31(34): 3442⁃3451. DOI: 10.1016/j.vaccine.2012.12.048.
|
[21] |
Hessenberger M, Weiss R, Weinberger EE, et al. Transcutaneous delivery of CpG⁃adjuvanted allergen via laser⁃generated micropores[J]. Vaccine, 2013, 31(34): 3427⁃3434. DOI: 10.1016/j.vaccine.2012.09.086.
|
[22] |
Zaric M, Lyubomska O, Poux C, et al. Dissolving microneedle delivery of nanoparticle⁃encapsulated antigen elicits efficient cross⁃priming and Th1 immune responses by murine Langerhans Cells[J]. J Invest Dermatol, 2015, 135(2): 425⁃34. DOI: 10.1038/jid.2014.415.
|
[23] |
Li N, Peng L, Chen X, et al. Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers[J]. Vaccine, 2011, 29(37): 6179⁃6190. DOI: 10.1016/j.vaccine.2011. 06.086.
|
[24] |
Senti G, von Moos S, Kündig TM. Epicutaneous immunotherapy for aeroallergen and food allergy[J]. Curr Treat Options Allergy, 2014, 1(1): 68⁃78.
|
[25] |
Senti G, von Moos S, Tay F, et al. Epicutaneous allergen⁃specific immunotherapy ameliorates grass pollen⁃induced rhinoconjunc⁃tivitis: a double⁃blind, placebo⁃controlled dose escalation study[J]. J Allergy Clin Immunol, 2012, 129(1): 128⁃135. DOI: 10.1016/j.jaci.2011.08.036.
|
[26] |
Agostinis F, Forti S, Di Berardino F. Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis[J]. Allergy, 2010, 65(3): 410⁃411. DOI: 10.1111/j.1398⁃9995.2009. 02189.x.
|
[27] |
田阳子, 李巍, 刘玉峰. 卵清蛋白经皮诱导免疫耐受机制初探[J].中国皮肤性病学杂志, 2011(08): 601⁃603.
|
|
Tian YZ, Li W, Liu YF. Immune tolerance induced by application of antigen onto intact skin and its mechanism[J]. Chin J Derm Venereol, 2011(08): 601⁃603.
|
[28] |
Bach D, Weiss R, Hessenberger M, et al. Transcutaneous immu⁃notherapy via laser⁃generated micropores efficiently alleviates allergic asthma in Phl p 5⁃sensitized mice[J]. Allergy, 2012, 67(11): 1365⁃1374. DOI: 10.1111/all.12005.
|
[29] |
Garaczi E, Szabo K, Francziszti L, et al. DermAll nanomedicine for allergen⁃specific immunotherapy[J]. Nanomedicine, 2013, 9(8): 1245⁃1254. DOI: 10.1016/j.nano.2013.05.011.
|
[30] |
Weiss R, Scheiblhofer S, Machado Y, et al. New approaches to transcutaneous immunotherapy: targeting dendritic cells with novel allergen conjugates[J]. Curr Opin Allergy Clin Immunol, 2013, 13(6): 669⁃676. DOI: 10.1097/ACI.0b013e328364f4df.
|